Concepedia

Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice

Masato Narita, Kenji Hanada, Yosuke Kawamura, Hiroaki Ichikawa, Shuntaro Sakai, Yoshikazu Yokono, Maiko Senoo, Noritomo Narita, Michiko Shimada, Tomohiro Osanai,

Hypertension Research · 2021 · 11 citations · 50 references

DOIFull text

Open access

Concepts

References

50

2013 ACCF/AHA Guideline for the Management of Heart Failure

Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt et al. · Journal of the American College of Cardiology · 2013 · 12.6K citations

, , +14

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

, , +15

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt et al. · Journal of the American College of Cardiology · 2017 · 3.4K citations

, , +11

Diastolic Heart Failure — Abnormalities in Active Relaxation and Passive Stiffness of the Left Ventricle

Michael R. Zile, Catalin F. Baicu, William H. Gaasch · New England Journal of Medicine · 2004 · 1.5K citations · Full text

, , +16

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction

Ramachandran S. Vasan, Emelia J. Benjamin, Jane C. Evans et al. · Journal of the American College of Cardiology · 1999 · 1.3K citations

, , +9